News Releases

These are news releases that are related to our Investor efforts.  Releases are listed in chronological order and are archived by year.  Sign-up to receive news as it is released using the email and RSS tools below.

Investor Alerts

Year All Years 2019 2018 2017 Keywords Go

Advanced Search

Search

  Search Headlines Only

From

To

Asset Types

 Photos  Video  Audio  Documents  Events  Standard

 Basic Search

• Jun 21, 2019

  Achieve Life Sciences Announces Phase 2b ORCA-1 Trial Data Accepted for Oral Presentation at Society for Research on Nicotine & Tobacco Europe (SRNT-E) 19th Annual Conference
• Jun 11, 2019

  Achieve Life Sciences Announces Statistically Significant Improvement in Quit Rates for Simplified Cytisinicline Dosing Schedule in Phase 2b ORCA-1 Dose-Selection Trial
• Jun 3, 2019

  Achieve Receives $4.2 Million from Exercise of Warrants
• May 30, 2019

  Achieve Announces Patent Granted in the U.S. for Novel Formulation of Cytisinicline
• May 15, 2019

  Achieve Reports Financial Results for First Quarter 2019 and Provides Cytisinicline Clinical Development Update

Show 5102550100 per page